Business Context and Reporting Period
This Form 8-K Current Report was filed by Becton, Dickinson and Company (BD) on October 21, 2021. The report discloses a corporate governance event regarding the Board of Directors.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on personnel changes and does not contain financial performance data.
Material Changes
The material change reported is the election of Carrie L. Byington, M.D. to the Board of Directors. Upon joining, Dr. Byington will serve on the Audit Committee and the Quality and Regulatory Committee. The Board has determined she is independent under NYSE rules.
Guidance, Outlook, and Compensation
There is no guidance, outlook, or management commentary regarding future financial performance in this filing. Regarding compensation, Dr. Byington will receive restricted stock units valued at $54,969, representing a prorated grant from the effective date of her election to the 2022 Annual Meeting of Shareholders.
Investor Verification Checklist
- Verify Dr. Byington's independence status and committee assignments in the company's proxy statement.
- Confirm the valuation and vesting terms of the restricted stock units granted to new directors.
- Review the 2021 Annual Meeting proxy statement for full details on non-management director compensation.